"Pharmacoequity" in Heart Failure Treatment: A Right for Everyone, Not Just a Select Few.

IF 10.3 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

JACC. Heart failure Pub Date : 2025-01-01 DOI:10.1016/j.jchf.2024.10.015

Ikeoluwapo Kendra Bolakale-Rufai, Khadijah Breathett

引用次数: 0

查看原文本刊更多论文

心力衰竭治疗中的“药物公平”：每个人的权利，而不仅仅是少数人的权利。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JACC. Heart failure CARDIAC & CARDIOVASCULAR SYSTEMS-

CiteScore

21.20

自引率

2.30%

发文量

164

期刊介绍： JACC: Heart Failure publishes crucial findings on the pathophysiology, diagnosis, treatment, and care of heart failure patients. The goal is to enhance understanding through timely scientific communication on disease, clinical trials, outcomes, and therapeutic advances. The Journal fosters interdisciplinary connections with neuroscience, pulmonary medicine, nephrology, electrophysiology, and surgery related to heart failure. It also covers articles on pharmacogenetics, biomarkers, and metabolomics.